Introduction
Extended-spectrum b-lactamases (ESBLs) production in Enterobacteriaceae is a serious problem worldwide. 1 Carbapenems, such as ertapenem, imipenem, and meropenem, would be the main therapeutic option for treatment of serious infections or against highly resistant Enterobacteriaceae with ESBLs. 2, 3 Recently, the rapid emergence and dissemination of carbapenem resistance in Enterobacteriaceae was reported.
4e6 These carbapenemresistant strains are characterized by their resistance to almost all b-lactam antibiotics, including the third-and fourth-generation cephalosporins, as well as to fluoroquinolones and aminoglycosides. 4e6 The mechanisms of carbapenem resistance in Enterobacteriaceae are through loss of porins in combination with the expression of AmpC enzymes or ESBLs or carbapenemase production. 7e10 Carbapenemases are divided into three classes: Ambler Class A (Klebsiella pneumoniae carbapenemase [KPC] , Serratia marcescens enzyme (Sme), non-metallocarbapenemase-A (NMC-A), imipenemase (IMI), plasmidic extended-spectrum b-lactamases (PER), class A b-lactamase with carbapenemase activity from Serratia fonticola (SFC), class A b-lactamase from Serratia fonticola (SFO), and some allelic variants of Guiana extended-spectrum b-lactamase/integron-borne cephalosporinase (GES/IBC)), Class B (Australia integronencoded metallo-b-lactamase (AIM), Germany integronencoded metallo-b-lactamase (GIM), imipenemase (IMP), New Delhi metallo-b-lactamase (NDM-1), Seoul integron-encoded metallo-b-lactamase (SIM), São Paulo metallo-b-lactamase (SPM), Verona integron-encoded metallo-b-lactamase (VIM)), and class D (oxacillinase (OXA) and Pseudomonas-specific enzymes (PSE)). 11 The rapid emergence and spread of carbapenemase-producing strains is caused by epidemics of bacteria bearing plasmids coding for KPC, IMP, VIM, NDM-1, and OXA-48 enzymes.
11 Therefore, confirmation of carbapenemase production is very important to controlling the spread of carbapenemase-producing bacteria.
The modified Hodge test, which was recommended by the Clinical Laboratory Standards Institute (CLSI), 12 is a phenotypic screening test providing for a high level of sensitivity (> 90%) and specificity (> 90%) in detecting KPCtype carbapenemase producers among Enterobacteriaceae. However, false-positive results were reported in species of Enterobacteriaceae, including Escherichia coli and K. pneumoniae and intrinsic chromosomal AmpC blactamase of Enterobacter cloacae and Serratia marcescens, and these false positive results may occur due to minor carbapenem hydrolysis by AmpC enzymes, ESBLs, or loss of porins. 3,13e16 A boronic acid-based method, using the 3-aminophenylboronic acid (APB)-imipenem combined disks, was reported to be promising in detection of the presence of Class A carbapenemases, and it had higher sensitivity and specificity than the modified Hodge test. 11,13e15,17 In this study, we aimed to perform a large-scale investigation into the characterization of the modified Hodge test-positive isolates of Enterobacteriaceae collected from 2006 to 2010 in Taiwan. Our data revealed that ESBLs, AmpC enzymes, and IMP-8 carbapenemase coupled with decreased expression of outer membrane protein were prevalent in Enterobacteriaceae isolates testing positive by the modified Hodge test. Moreover, based on our knowledge, this is the first report of false detection of carbapenemase by the modified Hodge test in Citrobacter freundii.
Methods

Clinical isolates
Previous reports showed that Gram-negative bacilli producing KPC-type carbapenemase were resistant to cephalosporins, whereas their susceptibilities to carbapenems covered a wide range. 2, 13, 16 Therefore, our isolates resistant to third-generation cephalosporins or intermediate or resistant to carbapenems recovered from 2006 to 2010 were collected and screened for the KPC-type carbapenemase by the modified Hodge test. A total of 56 isolates of Enterobacteriaceae (24 E. cloacae, 17 E. coli, 10 K. pneumoniae, and five C. freundii) with positive modified Hodge test were obtained from two medical centers, the Department of Pathology at the National Cheng Kung University Hospital and the Department of Laboratory Medicine at the China Medical University Hospital in Taichung, Taiwan. All strains were nonduplicates and were identified by colony morphology, Gram stain, biochemical tests, or Vitek system (BioMérieux, Marcy l'Etoile, France).
Antimicrobial susceptibility testing
Minimal inhibitory concentrations (MICs) of amikacin, aztreonam, cefepime, ceftazidime, ciprofloxacin, ertapenem, imipenem, levofloxacin, and meropenem (Sigma Chemical Co., St. Louis, MO USA) and gentamicin (Amresco Inc., Solon, OH USA) were determined in duplicate by the agar dilution method according to the recommendations of the CLSI. 12 Briefly, bacteria were suspended in saline to one-tenth the turbidity of the 0.5 McFarland standard, then inoculated directly onto antibiotic-containing Mueller-Hinton agar. After 16 to 20 hours of incubation, the MIC of each antibiotic was determined. E. coli ATCC 25922 was used as the quality control strain. The resistance breakpoints for these antimicrobial agents were determined according to the recommendations of the CLSI. 12 
Modified Hodge test
The modified Hodge test was performed as described by CLSI. 12 The enhanced growth of E. coli ATCC 25922 toward the ertapenem disk was interpreted as a positive result for carbapenemase production. K. pneumoniae ATCC BAA-1705 and ATCC BAA-1706 were used as the positive and negative quality control strains, respectively.
Boronic acid combined-disk test
Boronic acid compounds are effective as KPC inhibitors for the phenotypic detection of KPCs.
13e15,17 Two disks each containing ertapenem or imipenem (10 mg [BBL Microbiology Systems, Cockeysville, MD USA]) were placed on a Muller-Hinton agar plate inoculated with a tested strain and adjusted to a 0.5 McFarland standard. Ten microliters containing 400 mg of phenyl boronic acid (Sigma Chemical Co.) was added to one of the ertapenem or imipenem disks in each set. After incubation for 16 to 20 hours, enhancement of the zone of inhibition (! 5 mm) in the area between the ertapenem or imipenem disks with (as compared with without) phenyl boronic acid was considered to be a positive result. 17 The boronic acid combineddisk test was performed in duplicate and K. pneumoniae ATCC BAA-1705 and ATCC BAA-1706 were used as the positive and negative quality control strains, respectively.
b-lactamases detection assays
Screening for ESBLs in Enterobacteriaceae was according to the recommendation from CLSI, 12 using cefotaxime (30 mg) and ceftazidime (30 mg) alone and combined with clavulanic acid (10 mg [BBL Microbiology Systems]). Isolates were screened for AmpC and Class B carbapenemases with the boronic acid disk method and the 2-mercaptopropionic acid double-disk method, respectively. 18, 19 Identification of carbapenemase activities in crude extracts of bacterial isolates was performed by a spectrophotometric assay using imipenem as the substrate. 9, 13, 20 Briefly, the bacterial cells from an overnight culture were diluted 1:20 into fresh medium and incubated for 2 hours. The bacterial cells were suspended in a solution of 10 mM HEPES (pH 7.5) and disrupted by sonication. The supernatants were obtained by centrifugation at 5000 Â g for 10 to 15 minutes and 0.1 mM imipenem was added to measure carbapenemase activities by monitoring imipenem hydrolysis with a Beckman Coulter DU 800 UV/Vis Spectrophotometer (Beckman Coulter, Inc., Brea, CA USA) at 297 nm.
Outer membrane proteins analysis
Bacterial outer membrane proteins (OMPs) were isolated and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) through 10% SDS-PAGE with 4 M urea. 9 Purified OMPs were obtained by treatment of the cell envelopes with 2% sodium-N-lauryl sarcosinate (Sigma Chemical Co.). E. coli K12 was used as the control.
DNA isolation, polymerase chain reaction amplification, and direct sequencing Total DNA of Enterobacteriaceae was extracted and suspended in 500 mL of 1 Â Tris-ethylenediaminetetraacetic acid (EDTA) buffer. Cell suspensions were transferred to boiling water for 20 minutes. Cell debris was removed by centrifugation, and 2 mL of supernatant was used as a source of template DNA in a 50-mL polymerase chain reaction. Strains were analyzed for carbapenemase (bla KPC , bla GES , bla IMP , bla OxA , and bla PSE ) and b-lactamase genes (bla CMY , bla CTx-M , bla DHA , bla SHV , and bla TEM ), using the primers described previously. 6, 9 The purified polymerase chain reaction products were directly sequenced using the automated ABI PRISM 3730 DNA sequencer (Applied Biosystems, Foster, CA USA).
Results
Antibiotic susceptibility of Enterobacteriaceae strains positive for the modified Hodge test
A total of 56 modified Hodge test positive isolates collected from 2006 to 2010, including 24 E. cloacae, 17 E. coli, 10 K. pneumoniae, and five C. freundii, were investigated. These isolates were resistant to ceftazidime (100%), aztreonam (82.1%), ertapenem (64.3%), gentamicin (53.6%), ciprofloxacin (50%), levofloxacin (48.2%), cefepime (19.6%), imipenem (16.1%), meropenem (12.5%), and amikacin (8.9%). The results are shown in Table 1 .
Phenotypic and genotypic screening of modified Hodge test positive Enterobacteriaceae strains
The boronic acid combined-disk test was used to screen for the presence of Class A carbapenemases among strains with positive modified Hodge test results. There were four (7.1%) isolates, including two E. cloacae, one E. coli, and one K. pneumoniae, positive for Class A carbapenemases (enhancement of the inhibition diameter between 6e14 and 4e7 mm using ertapenem and imipenem disks, respectively). However, no imipenem hydrolysis was detected among these isolates through spectrophotometric assay. In addition, phenotypic testing among isolates with modified Hodge test positive results revealed the production of ESBLs, MBLs, and AmpC in 10 (17.9%), 16 (28.6%), and 12 (44.4%) isolates, respectively. Three K. pneumoniae isolates expressed a coexisting phenotype of ESBLs and AmpC.
Carbapenemase and noncarbapenemase b-lactamase genes were analyzed by polymerase chain reaction, which revealed the presence of bla TEM-1 , bla SHV , bla CTx-M , bla IMP-8 , bla CMY-2 , and bla DHA-1 were found in 32 (57.1%), 19 (33.9%), four (7.1%), 16 (28.6%), 14 (25%), and five (8.9%), respectively. The bla SHV-12 predominates (78.9%) among all of the tested bla SHV -positive strains, and bla SHV-5 (10.5%) and bla SHV-11 (10.5%) were only detected in K. pneumoniae. The bla CTx-M-14 (50%) and bla CTx-M-22 (50%) were presented in one E. coli and three K. pneumoniae, respectively. No Class A and D carbapenemase genes (bla KPC , bla GES , bla PER , bla OxA , and bla PSE ) were detected among these isolates. Fourteen (25%) of the 56 isolates ( 
Discussion
This is the first large-scale study of investigate the characterization of the modified Hodge test-positive isolates of Enterobacteriaceae, and we found that strains carrying ESBLs, AmpC enzymes, and IMP-8 carbapenemase, as well as decreased of outer membrane proteins, were prevalent among Enterobacteriaceae isolates in Taiwan. The CLSI recommends detecting KPC-type carbapenemase producers in Enterobacteriaceae using the modified Hodge test. 12 However, false positive results were reported in Brazil. 3 They found that cefotaxime-M b-lactamase (CTX-M), particularly CTX-M-2, combined with porin loss in K. pneumoniae, was highly prevalent in strains with false detection of carbapenemase by the modified Hodge test. 3 Moreover, Pasteran and colleagues 13, 14 also showed that false positive results were acquired from K. pneumoniae, E. cloacae, E. coli, and S. marcescens using the modified Hodge test in Argentina. Among them, false positive results were mainly due to strains harboring CTX-M-2, AmpC hyperproducers, and loss of porins. 13, 14 Therefore, in different geographic areas, isolates without KPC production may, through various mechanisms, present false positive results when performing the modified Hodge test.
KPC-producing Enterobacteriaceae are widespread in Israel, Greece, South America, and the United States. 2 In China, particularly in the Zhejiang Province, KPC-2 was increasingly reported in K. pneumoniae and also in C. freundii, E. coli, and S. marcescens.
2 However, no KPC was described previously in Taiwan. Therefore, strains with positive results from the modified Hodge test need to be further investigated for the presence of Class A carbapenemase genes. Recently, the first arrival of KPC-2-producing K. pneumoniae was reported in Taiwan from a businessman working in the Zhejiang Province of China. To prevent spreading KPC-producing bacteria in Taiwan, continually monitoring KPC producers is required. A boronic acid-based method using the APB-imipenem combined disks was reported to have 100% of sensitivity and specificity in detecting Class A carbapenemases in Enterobacteriaceae.
11,13 Recent study tested the effect of phenyl boronic acid on detection of KPC carbapenemaseproducing Enterobacteriaceae. 17 The comparative study showed that the imipenem and meropenem disk with 400 mg phenyl boronic acid exhibits the 100% of sensitivity and 97.6% of specificity in the phenotypic detection of KPC producers. 17 Our four isolates, including two E. cloacae, one E. coli, and one K. pneumoniae, tested positive with the phenyl boronic acid-imipenem combined disks (enhancement of the inhibition diameters between 6e14 and 4e7 mm using ertapenem and imipenem disks, respectively). However, no imipenem hydrolysis or carbapenemase gene was detected through spectrophotometric assay and polymerase chain reaction, respectively, among these isolates. This indicates that few false positive results were obtained using carbapenem disks and 400 mg phenyl boronic acid as an inhibitor to detect Class A carbapenemase producers among Enterobacteriaceae in our isolates.
There were 14 (25%) isolates (13 E. cloacae and one E. coli), with ertapenem MICs between 0.25e64 mg/mL, which presented negative results for all of the genotypic tests for detecting AmpC, ESBLs, and Classes A, B, and D carbapenemases. There have been reported that intrinsic chromosomal AmpC b-lactamase expression of E. cloacae and S. marcescens may show positive results when doing the modified Hodge test. 13, 14 Therefore, highly chromosomal AmpC production is also involved in acquiring positive results by the modified Hodge test in Enterobacteriaceae in Taiwan. Loss of outer membrane proteins has been reported in E. coli, E. cloacae, and K. pneumoniae, resulting in false detection of carbapenemase by the modified Hodge test. 3,13e16 Moreover, loss of OmpC/F and OmpK35/36 is commonly encountered in ertapenem-resistant E. coli and K. pneumoniae in Taiwan. 6, 9, 22 Based on the outer membrane protein profile analysis, our modified Hodge test-positive isolates showed obviously decreased expression of the outer membrane protein in 49 (87.5%) isolates. In addition, two studies has been reported that absence or decreased expression of two outer membrane proteins (the 41-and 38-kDa porins) may also contributed to carbapenem resistance in C. freundii. 23, 24 Among our five chromosomal AmpC-producing C. freundii with low level resistance to ertapenem, all of them revealed that the levels of the 38-kDa protein were decreased compared with C. freundii ATCC 8090. This indicates that loss or decreased expression of outer membrane protein coupled with ESBLs, MBLs, and AmpC phenotypes contributed to the strains with positive results from the modified Hodge test.
In conclusion, our data revealed that ESBLs, AmpC enzymes, and IMP-8 carbapenemase coupled with the decreased expression of the outer membrane protein were prevalent in Enterobacteriaceae isolates with positive modified Hodge test results. Clinical microbiology laboratories should be careful to test for Class A carbapenemase genes to prevent incorrect reporting as KPC-type carbapenemase producers as a result of performing the modified Hodge test.
